Personalized Anti-Inflammatory Systems

The present invention relates to the integration of anti-inflammatory peptides with advanced technologies such as AI, IoT, blockchain, and biodegradable nanomaterials to create personalized treatment systems for inflammatory diseases.

The original patent disclosed anti-inflammatory peptides and compositions for treating dermal related inflammatory diseases. However, the peptides' efficacy and safety were limited by their administration routes, dosages, and individual variability in response. The present invention addresses these limitations by incorporating machine learning, IoT, blockchain, and advanced biomaterials to create a more effective and personalized treatment approach.

The inventive concept comprises a system that integrates anti-inflammatory peptides with AI-powered analytics to predict optimal treatment outcomes based on a subject's genetic profile and medical history. The system utilizes wearable IoT devices to track the subject's physiological response to the peptide and blockchain technology to securely store and analyze the subject's medical data. Additionally, the system incorporates biodegradable nanomaterials to enhance the peptide's bioavailability and stability. The inventive concept also includes a method for generating personalized anti-inflammatory peptides using AI-driven molecular design and simulation tools, which are optimized for specific inflammatory disorders and produced using advanced biomanufacturing techniques.

The present invention's novelty lies in the synergistic combination of anti-inflammatory peptides with advanced technologies to create a personalized treatment system. The inventive step is the integration of these distinct technologies to address the limitations of the original patent and provide a more effective and targeted treatment approach.

Alternative embodiments of the inventive concept include the use of different AI algorithms, IoT devices, and biomaterials. Variations of the system could include the integration of additional technologies such as gene editing or stem cell therapy to further enhance the treatment's efficacy and personalization.

The inventive concept has significant commercial potential in the pharmaceutical and biotechnology industries, particularly in the treatment of inflammatory diseases such as psoriasis, arthritis, and inflammatory bowel disease. The system's ability to provide personalized treatment approaches could revolutionize the field of inflammatory disease treatment and improve patient outcomes.